LSBCF (LakeShore Biopharma Co) 3-1 Month Momentum %: 122.22% (As of Jul. 09, 2026)


What is LakeShore Biopharma Co 3-1 Month Momentum %?

LakeShore Biopharma Co LSBCF 3-1 Month Momentum % is 122.22% as of Jul. 09, 2026.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-09), LakeShore Biopharma Co's 3-1 Month Momentum % is 122.22%.

The industry rank for LakeShore Biopharma Co's 3-1 Month Momentum % or its related term are showing as below:

LSBCF's 3-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -11.025 vs LSBCF: 122.22

LakeShore Biopharma Co  (OTCPK:LSBCF) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

LakeShore Biopharma Co 3-1 Month Momentum % Related Terms

LSBCF vs ACUT, PPCB, ENSC: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's 3-1 Month Momentum % falls into.


LakeShore Biopharma Co  (OTCPK:LSBCF) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 122.22% mean?
LakeShore Biopharma Co (LSBCF) has a 3-1 Month Momentum % of 122.22% as of Jul. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's 3-1 Month Momentum % too high?
LakeShore Biopharma Co's current 3-1 Month Momentum % is 122.22%.
How does LakeShore Biopharma Co's 3-1 Month Momentum % compare to ACUT and PPCB?
LakeShore Biopharma Co's 3-1 Month Momentum % of 122.22% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current 3-1 Month Momentum % is 122.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current 3-1 Month Momentum % of 122.22%. The current 3-1 Month Momentum % is 122.22%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current 3-1 Month Momentum % is 122.22% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.